MyFinsight
Home
Blog
About
US
$1,283M
(4.39%↑ Y/Y)
Non Us
$414M
(-10.20%↓ Y/Y)
US
$510M
(41.27%↑ Y/Y)
Non Us
$443M
(32.24%↑ Y/Y)
US
$478M
(-35.84%↓ Y/Y)
Non Us
$281M
(-25.46%↓ Y/Y)
US
$550M
(39.24%↑ Y/Y)
Non Us
$164M
(33.33%↑ Y/Y)
US
$574M
(-3.85%↓ Y/Y)
Non Us
$6M
(-14.29%↓ Y/Y)
US
$520M
(11.59%↑ Y/Y)
Non Us
$56M
(43.59%↑ Y/Y)
US
$431M
(-15.82%↓ Y/Y)
Non Us
$60M
(-43.40%↓ Y/Y)
Revenue From Contract
With Customer...
$486M
(42.11%↑ Y/Y)
US
$285M
(5.56%↑ Y/Y)
Non Us
$187M
(64.04%↑ Y/Y)
US
$275M
(20.61%↑ Y/Y)
Non Us
$155M
(9.93%↑ Y/Y)
US
$399M
(14.33%↑ Y/Y)
Non Us
$1M
(-99.78%↓ Y/Y)
Non Us
$258M
(2.38%↑ Y/Y)
US
$94M
(-12.15%↓ Y/Y)
US
$187M
(-46.11%↓ Y/Y)
Non Us
$165M
(-10.81%↓ Y/Y)
Non Us
$171M
(6.21%↑ Y/Y)
US
$167M
(15.97%↑ Y/Y)
US
$317M
(-74.21%↓ Y/Y)
Non Us
$18M
(-96.10%↓ Y/Y)
US
$201M
(-13.36%↓ Y/Y)
Non Us
$113M
(-22.60%↓ Y/Y)
US
$233M
(-81.04%↓ Y/Y)
Non Us
$55M
(-88.07%↓ Y/Y)
Other Products
$1,697M
(0.41%↑ Y/Y)
Repathaevolocumab
$953M
(36.93%↑ Y/Y)
Prolia
$759M
(-32.35%↓ Y/Y)
EVENITY
$714M
(37.84%↑ Y/Y)
Enbrel
$580M
(-3.97%↓ Y/Y)
TEPEZZA
$576M
(14.06%↑ Y/Y)
Otezla
$491M
(-20.55%↓ Y/Y)
TEZSPIRE
$486M
(42.11%↑ Y/Y)
BLINCYTO
$472M
(22.92%↑ Y/Y)
Nplate
$430M
(16.53%↑ Y/Y)
KRYSTEXXA
$400M
(14.61%↑ Y/Y)
Aranesp
$352M
(-1.95%↓ Y/Y)
Xgeva
$352M
(-33.83%↓ Y/Y)
Vectibix
$338M
(10.82%↑ Y/Y)
UPLIZNA
$335M
Kyprolis
$314M
(-16.93%↓ Y/Y)
IMDELLTRAIMDYLLTRA
$288M
Product
$9,537M
(8.73%↑ Y/Y)
Product And Service
Other
$517M
(26.72%↑ Y/Y)
Total revenues
$10,054M
(9.53%↑ Y/Y)
Operating income
$3,514M
(32.30%↑ Y/Y)
Total operating
expenses
$6,540M
(0.26%↑ Y/Y)
Income before income
taxes
$2,768M
(76.53%↑ Y/Y)
Interest expense, net
$673M
(-3.03%↓ Y/Y)
Other (expense)
income, net
-$73M
(81.47%↑ Y/Y)
Cost of sales
$2,811M
(-6.64%↓ Y/Y)
Research and development
$1,868M
(7.11%↑ Y/Y)
Selling, general and
administrative
$1,745M
(3.19%↑ Y/Y)
Other
$116M
(50.65%↑ Y/Y)
Net income
$2,375M
(65.85%↑ Y/Y)
Provision for income taxes
$393M
(188.97%↑ Y/Y)
Back
Back
Income Statement
amgen-blue-svg
AMGEN INC (AMGN)
amgen-blue-svg
AMGEN INC (AMGN)
source: myfinsight.com